Voya Investment Management LLC Athenex, Inc. Transaction History

Voya Investment Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.91 $12,379 - $27,475	-30,193 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.36 - $2.94 $5,521 - $11,936	-4,060 Reduced 11.85%	30,193 $41,000
Q2 2021 Aug 16, 2021	BUY	$3.71 - $5.13 $2,901 - $4,011	782 Added 2.34%	34,253 $158,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $22,187 - $80,210	5,438 Added 19.4%	33,471 $144,000
Q4 2020 Feb 16, 2021	BUY	$11.06 - $14.01 $63,694 - $80,683	5,759 Added 25.86%	28,033 $310,000
Q3 2020 Nov 16, 2020	SELL	$10.26 - $14.55 $36,812 - $52,205	-3,588 Reduced 13.87%	22,274 $270,000
Q2 2020 Aug 14, 2020	SELL	$7.11 - $13.76 $65,212 - $126,206	-9,172 Reduced 26.18%	25,862 $356,000
Q1 2020 May 15, 2020	BUY	$5.71 - $15.85 $7,748 - $21,508	1,357 Added 4.03%	35,034 $271,000
Q4 2019 Feb 14, 2020	BUY	$9.6 - $17.75 $68,198 - $126,096	7,104 Added 26.73%	33,677 $514,000
Q3 2019 Nov 14, 2019	BUY	$12.16 - $21.0 $46,159 - $79,716	3,796 Added 16.67%	26,573 $323,000
Q2 2019 Aug 14, 2019	BUY	$9.44 - $19.8 $45,784 - $96,030	4,850 Added 27.05%	22,777 $451,000
Q4 2018 Feb 14, 2019	BUY	$10.24 - $15.49 $21,964 - $33,226	2,145 Added 13.59%	17,927 $227,000
Q2 2018 Aug 14, 2018	BUY	$15.88 - $19.5 $250,618 - $307,749	15,782 New	15,782 $294,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.